PeptidePedia The community reference

Special:RecentChanges

Change log·6,798 revisions·page 57 of 68

Every change to PeptidePedia Wiki, newest first. N marks a new page, m a minor edit and b an edit by an approved bot. The byte figure is the page size after the edit; the coloured figure is the change. 6,798 changes are logged in total.

6,798Logged changes
575Bot edits
167Page creations
256Active editors

15 November 2024

  1. (diff | hist) m 12:26 Proglucagon 3,465 +27 IncretinIvo (talk | contribs) close an unbalanced quotation mark [rollback]
  2. (diff | hist) m 11:04 Repackaging 2,904 +444 FreightFenna (talk | contribs) add the figure for the lyophilisation cycle and caption it [rollback]
  3. (diff | hist) N 09:00 Customs seizure 1,052 +1,052 FiveOhThreeA (talk | contribs) create article — regulatory stub
  4. (diff | hist) 02:02 Insulin syringe 2,889 +99 DrTitration (talk | contribs) add the cross-link to the calculator page [rollback]

14 November 2024

  1. (diff | hist) m 22:09 Chain of custody 2,966 ±0 TrialsTabitha (talk | contribs) correct the description of the sampling procedure [rollback]
  2. (diff | hist) 19:59 USP General Chapter 71 1,714 ±0 DrTitration (talk | contribs) typo [rollback]
  3. (diff | hist) 18:23 Peptide aggregation 3,043 +356 TFA_Counterion (talk | contribs) clarify that area percent is not mass percent [rollback]
  4. (diff | hist) 17:33 Batch number 2,982 +488 UnderfillUna (talk | contribs) ce, tighten prose [rollback]
  5. (diff | hist) m 11:56 HOMA-IR 2,317 +32 UACR_Ulric (talk | contribs) add the note that a single value out of range is not a finding [rollback]
  6. (diff | hist) 11:47 Talk:Peptide content 1,033 +60 AAA_Analyst (talk | contribs) /* Typical content range: is 70–90% defensible? */ reply
  7. (diff | hist) 07:59 ChinaPeptides 2,933 ±0 IsocraticIla (talk | contribs) split §Operations from §Product range [rollback]
  8. (diff | hist) 07:53 Custom peptide synthesis 2,690 +283 MelanocortinMil (talk | contribs) add the collapse-temperature point, sourced [rollback]
  9. (diff | hist) 00:25 Timeline of incretin therapeutics 2,352 ±0 DulaglutideDug (talk | contribs) expand §Physiology [rollback]

13 November 2024

  1. (diff | hist) m 23:35 Certificate of analysis 5,485 ±0 ForgeryFinder (talk | contribs) expand §The fields most often missing [rollback]
  2. (diff | hist) m b 21:16 Adverse effects of GLP-1 receptor agonists 3,171 +34 StubSorterBot (talk | contribs) bot: flag bare reference [rollback]
  3. (diff | hist) 20:03 Fmoc chemistry 3,388 +40 PrepHPLC_Pia (talk | contribs) space between number and unit per PP:MOS [rollback]
  4. (diff | hist) 17:40 Karl Fischer titration 5,150 +184 ChromCleanupCass (talk | contribs) expand §Volumetric and coulometric variants [rollback]
  5. (diff | hist) m b 17:37 Chinese Peptide Company 5,891 ±0 StubSorterBot (talk | contribs) bot: add supplier category [rollback]
  6. (diff | hist) 16:49 Good manufacturing practice 2,501 +29 DeadSpaceDot (talk | contribs) split overlong sentence [rollback]
  7. (diff | hist) 16:39 Residual solvent 2,880 ±0 SigFigSindri (talk | contribs) fix a broken wikilink [rollback]
  8. (diff | hist) 15:14 Body composition assessment 1,910 +775 HOMA_Hettie (talk | contribs) typo [rollback]
  9. (diff | hist) 09:02 Talk:Peptide content 822 +177 KarlFischerKit (talk | contribs) /* Typical content range: is 70–90% defensible? */ reply
  10. (diff | hist) m b 07:50 Growth hormone secretagogue 1,842 ±0 ArchiveBot (talk | contribs) bot: add stub category [rollback]

12 November 2024

  1. (diff | hist) 19:52 Arcuate nucleus 3,033 +333 GsCouplingGil (talk | contribs) add the cleavage site by residue number [rollback]
  2. (diff | hist) 19:20 Nantong Guangyuan Chemical 6,444 +201 PeakShapePol (talk | contribs) add the incorporation year, attributed to the registry record [rollback]
  3. (diff | hist) 14:36 Talk:Peptide content 611 +241 TFA_Counterion (talk | contribs) /* Typical content range: is 70–90% defensible? */ reply
  4. (diff | hist) 14:11 Oral semaglutide 2,537 ±0 CRP_Cormac (talk | contribs) fix a dangling clause [rollback]
  5. (diff | hist) 13:52 Reconstitution of lyophilised peptides 3,118 ±0 DeadSpaceDot (talk | contribs) give the worked example to two significant figures throughout [rollback]
  6. (diff | hist) m b 13:31 Area percent purity 3,599 +221 CategoryBot (talk | contribs) bot: flag bare reference [rollback]
  7. (diff | hist) 10:50 Drug master file 1,789 +238 ImportRecordIna (talk | contribs) sentence case in headings per PP:MOS [rollback]
  8. (diff | hist) m 10:30 Deamidation 2,020 ±0 ResolutionRoo (talk | contribs) give the limit of quantitation with the signal-to-noise ratio it assumes [rollback]
  9. (diff | hist) 10:23 Cold-chain freight 2,114 +214 DiluentDiya (talk | contribs) add the excursion tolerance with the study it derives from [rollback]
  10. (diff | hist) 10:19 Talk:Peptide content 400 +209 AAA_Analyst (talk | contribs) /* Typical content range: is 70–90% defensible? */ new section
  11. (diff | hist) N 09:00 Underfilling 1,108 +1,108 GastroparesisGwen (talk | contribs) create article — testing stub
  12. (diff | hist) m 06:54 Baseline laboratory panel 1,947 ±0 Compounding_Cate (talk | contribs) state whether the figure is a mean or a median [rollback]
  13. (diff | hist) m 06:23 Number needed to treat 2,280 +296 ForestPlotFinn (talk | contribs) copyedit [rollback]
  14. (diff | hist) 05:29 Peptide 4,033 +130 PrepHPLC_Pia (talk | contribs) add the note that lyophilised material tolerates excursions better than solution [rollback]
  15. (diff | hist) 04:45 Crude peptide 2,632 ±0 CounterfeitCato (talk | contribs) correct the transit-time figure — the source gives a median, not a maximum [rollback]

11 November 2024

  1. (diff | hist) 22:25 Contract development and manufacturing organisation 2,252 +925 SPPS_Sorrel (talk | contribs) rm the shipping recommendation — that is advice, not description [rollback]
  2. (diff | hist) m 22:03 TRIUMPH trial programme 2,837 +357 NeutralNikolai (talk | contribs) add the year of publication to each trial in the list [rollback]
  3. (diff | hist) 19:52 Limit of detection 3,509 +920 IsocraticIla (talk | contribs) sentence case in headings per PP:MOS [rollback]
  4. (diff | hist) m 17:15 Hunan Aslsen Technology 4,906 +641 HyphenHarriet (talk | contribs) add the incorporation year, attributed to the registry record [rollback]
  5. (diff | hist) 13:19 Beyond-use date 4,878 +614 LedeLeander (talk | contribs) expand §Opened containers [rollback]
  6. (diff | hist) 11:14 Contraindications of incretin therapy 2,065 +588 ClinicCorrespondent (talk | contribs) fix a dangling clause [rollback]
  7. (diff | hist) 10:52 Mass spectrometry 3,881 +41 Chromatokid (talk | contribs) state the column chemistry and the gradient the figure was obtained on [rollback]
  8. (diff | hist) N 10:38 Body composition assessment 1,135 +1,135 PlainNumbersPip (talk | contribs) create article — laboratory stub
  9. (diff | hist) 10:26 Methionine oxidation 1,416 ±0 ColumnOvenCoy (talk | contribs) rm the claim that the method is stability-indicating without a forced-degradation study [rollback]
  10. (diff | hist) 10:18 FLOW trial 2,601 +444 StyleSheetSybil (talk | contribs) the article attributed a finding to the wrong trial in the programme [rollback]
  11. (diff | hist) 04:32 Shanghai Sigma-Audley New Material Technology 2,340 ±0 BetaCellBoyd (talk | contribs) correct the trading name — the short code and the legal name are different things [rollback]

10 November 2024

  1. (diff | hist) m 23:55 CagriSema 2,261 ±0 DulaglutideDug (talk | contribs) reorder the analogues chronologically rather than alphabetically [rollback]
  2. (diff | hist) m 21:38 Analytical method validation 2,979 ±0 GlossaryGleb (talk | contribs) convert the method-comparison paragraph to a table [rollback]
  3. (diff | hist) 20:24 Insulin syringe unit conversion 1,495 ±0 CostPerMgCory (talk | contribs) clarify which figures are measured and which are derived [rollback]
  4. (diff | hist) 16:42 Incretin effect 4,982 +122 ITT_Imelda (talk | contribs) rm the causal claim about appetite — the cited work is associative [rollback]
  5. (diff | hist) 14:45 Tianjin Finder Chemical 2,727 +1,045 EndotoxinEd (talk | contribs) state which lines are held in regional stock [rollback]
  6. (diff | hist) 14:43 Research use only 3,726 ±0 API_Aurora (talk | contribs) clarify that a business licence is not a manufacturing authorisation [rollback]
  7. (diff | hist) 13:25 Retention time 2,901 +618 Retention_Time_Rae (talk | contribs) add the counterion determination method by name [rollback]
  8. (diff | hist) 12:19 List of GLP-1 receptor agonists 2,606 +349 UnitsUrsula (talk | contribs) sort the list by the column the lead says it is sorted by [rollback]
  9. (diff | hist) m 10:06 Glossary of peptide terminology 3,473 +35 LeaderLoic (talk | contribs) add the column header that was missing [rollback]
  10. (diff | hist) 09:58 Survodutide 1,456 ±0 NauseaNoor (talk | contribs) ce per PP:MOS [rollback]
  11. (diff | hist) 08:15 Glucose-dependent insulinotropic polypeptide 5,459 +159 AmylinAmos (talk | contribs) add the reference range with the assay it was established on [rollback]
  12. (diff | hist) 02:47 Purity claim inflation 2,238 ±0 EpitalonEoin (talk | contribs) expand §What a purity figure does establish [rollback]
  13. (diff | hist) m 00:06 Lixisenatide 2,047 +276 DulaglutideDug (talk | contribs) add the peptide length to the infobox [rollback]

9 November 2024

  1. (diff | hist) m b 22:28 Janoshik Analytical 3,638 +667 CategoryBot (talk | contribs) bot: update parent category chain [rollback]
  2. (diff | hist) 20:24 Peptide supply chain 3,539 +901 CRP_Cormac (talk | contribs) expand §Handovers, and why they are where things go missing [rollback]
  3. (diff | hist) m 17:29 Albumin binding half-life extension 3,157 ±0 SatietySunniva (talk | contribs) attribute the receptor-density claim to the tissue study it comes from [rollback]
  4. (diff | hist) 12:47 Dipeptidyl peptidase-4 4,168 +156 SatietySunniva (talk | contribs) add see also to the sister hormone [rollback]
  5. (diff | hist) m b 06:57 Reconstitution calculator 3,369 +466 ArchiveBot (talk | contribs) bot: sort category members [rollback]
  6. (diff | hist) 05:37 Amylin receptor agonist 2,536 +308 MolarMassMaeve (talk | contribs) fix a dangling clause [rollback]
  7. (diff | hist) 04:30 Trifluoroacetate counterion 2,739 +26 FreightFenna (talk | contribs) correct the resolution formula — the denominator is the sum of the widths [rollback]
  8. (diff | hist) 03:21 High-performance liquid chromatography 4,203 +37 SurpassSunniva (talk | contribs) expand §Hyphenated and preparative variants [rollback]
  9. (diff | hist) 01:57 SUSTAIN trial programme 3,694 +34 LipidLedgerLou (talk | contribs) add category for the trial programme [rollback]
  10. (diff | hist) 01:37 LEADER trial 2,357 ±0 PioneerPerdita (talk | contribs) give the absolute risk difference alongside the relative one [rollback]

8 November 2024

  1. (diff | hist) 23:08 VendorInvestigate 2,850 ±0 DefinedTermDov (talk | contribs) rm a duplicated category [rollback]
  2. (diff | hist) 21:29 Regulatory status by jurisdiction 2,139 +824 StateBoardStace (talk | contribs) add the note that a certificate of analysis has no regulatory standing [rollback]
  3. (diff | hist) 14:16 Medutest 2,738 ±0 Chromatokid (talk | contribs) state what the certificate actually carries, field by field [rollback]
  4. (diff | hist) m 14:10 GL Biochem (Shanghai) 7,660 +284 INN_Ingrid (talk | contribs) expand §Notability and coverage [rollback]
  5. (diff | hist) 12:15 Test report forgery 1,998 ±0 DeadSpaceDot (talk | contribs) expand §Internal signals [rollback]
  6. (diff | hist) 10:08 Bacteriostatic water 2,831 +24 Retention_Time_Rae (talk | contribs) state that reconstituted material should not be frozen, with the source [rollback]
  7. (diff | hist) N 09:00 Contract development and manufacturing organisation 1,327 +1,327 MoveRequestMio (talk | contribs) new article: supply and handling, expansion welcome
  8. (diff | hist) m 03:21 Exenatide 2,935 +199 SVG_Solomon (talk | contribs) space between number and unit per PP:MOS [rollback]

7 November 2024

  1. (diff | hist) m 20:40 PeptideMeter 2,876 +116 COA_Colwyn (talk | contribs) state the date range the submitted set covers [rollback]
  2. (diff | hist) m 16:08 Blind sampling 3,694 +220 SPPS_Sorrel (talk | contribs) serial comma per PP:MOS [rollback]
  3. (diff | hist) 11:33 Talk:Peptide supply chain 1,033 +97 HyphenHarriet (talk | contribs) /* The empty cell in the last row of the table */ reply
  4. (diff | hist) 10:38 Guangzhou JEEP Biotechnology 7,178 +1,812 ChainCustodyChad (talk | contribs) convert the product range to a table so the documentation column lines up [rollback]
  5. (diff | hist) m 07:43 STEP trial programme 3,909 +585 TSH_Tallulah (talk | contribs) the percentage quoted was placebo-adjusted; label it [rollback]
  6. (diff | hist) 02:45 USP General Chapter 85 2,086 ±0 UnitsUrsula (talk | contribs) state the column chemistry and the gradient the figure was obtained on [rollback]
  7. (diff | hist) 02:41 Qingdao Sigma Chemical 5,276 +804 COA_Colwyn (talk | contribs) convert the product range to a table so the documentation column lines up [rollback]

6 November 2024

  1. (diff | hist) 23:17 SURMOUNT trial programme 2,668 ±0 OpenLabelOtto (talk | contribs) add the number randomised and the number completing [rollback]
  2. (diff | hist) m b 22:47 Vial filling and stoppering 2,015 ±0 StubSorterBot (talk | contribs) bot: normalise temperature formatting [rollback]
  3. (diff | hist) 17:03 GLP-1 receptor agonist 6,539 +232 TriumphThad (talk | contribs) rm the comparison to a compound with no published head-to-head data [rollback]
  4. (diff | hist) 17:01 Prescribing information 2,473 ±0 BUD_Bertram (talk | contribs) correct the deductible description [rollback]
  5. (diff | hist) 16:50 Drug master file 1,551 ±0 MassSpecMarv (talk | contribs) add the note that a certificate of analysis has no regulatory standing [rollback]
  6. (diff | hist) m 13:21 Bacterial endotoxin test 2,929 ±0 ResolutionRoo (talk | contribs) expand §Methods [rollback]
  7. (diff | hist) 12:02 GLP-1 receptor 5,068 +204 DPP4_Dagmar (talk | contribs) the numbers in the lead disagreed with the body; body was right [rollback]
  8. (diff | hist) 09:07 Talk:Peptide supply chain 822 +135 FreightFenna (talk | contribs) /* The empty cell in the last row of the table */ reply
  9. (diff | hist) N 09:00 Survodutide 1,456 +1,456 IncretinIvo (talk | contribs) create article — compound stub
  10. (diff | hist) m b 06:29 Preparative HPLC purification 3,361 ±0 CategoryBot (talk | contribs) bot: flag bare reference [rollback]
  11. (diff | hist) m 05:50 WuXi TIDES 5,916 ±0 ReportReaderRilla (talk | contribs) convert a hard-coded date to the house format [rollback]
  12. (diff | hist) m 01:32 Loss on drying 2,569 ±0 MassSpecMarv (talk | contribs) add the forced-degradation conditions the claim rests on [rollback]
  13. (diff | hist) m 01:02 Gastric emptying 3,792 +639 AnalyticalAnnie (talk | contribs) sentence case in headings per PP:MOS [rollback]